Spelling suggestions: "subject:"citamin k"" "subject:"bitamin k""
31 |
Studies on the dietary requirements of growing chicks and breeding hens Part I. Studies on nutritional encephalomalacia. Part II. Hatchability with soybean oil meal as a protein supplement. Part III. Studies on the vitamin K requirements of breeding hens /Cravens, William Windsor, January 1940 (has links)
Thesis (Ph. D.)--University of Wisconsin--Madison, 1940. / Typescript. Includes abstract and vita. eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references (leaves 67-68).
|
32 |
Vitamin K Deficiency in the Setting of Blenderized Tube Feeding Regimen in a Teenager: A Case ReportKhan, Natasha, Taimur, M, Malkani, A, Lamsal, Riwaaj 11 January 2022 (has links)
Vitamin K acts a cofactor for the gamma-carboxylation of several proteins in the coagulation cascade. The clinical spectrum of vitamin K deficiency (VKD) can be asymptomatic to a significant bleeding. VKD is classically seen in newborns. However, this can manifest later in patients with risks such as sub-optimal nutrition, fat malabsorption, medications including antibiotics. A 17-year-old male with spinal muscular atrophy (SMA) Type 1, tracheostomy with ventilator dependent, gastrostomy tube feeding was seen by the gastroenterologist following treatment for small intestinal bacterial overgrowth (SIBO). Investigations showed coagulopathy following which he was transferred to the Pediatric ICU. Labs revealed prothrombin time (PT) 114 s [Normal 9.4-12.5 s], INR (International normalized ratio) 12.6 [Normal < 1.1] and partial thromboplastin time (PTT) 90 s [Normal 25.1-36.5 s]. Mixing studies and coagulation assays were consistent with VKD (low Factor VII and Factor IX with normal Factor V). His home blenderized feeding regimen met the caloric requirement but not the adequate intake (AI) values for vitamin K and other minerals. He received intravenous vitamin K (phytonadione) for five consecutive days with resolution of the coagulopathy (PT 13.2 s, PTT 37.1 s, INR 1.2). The patient was discharged on enteral vitamin K and additional supplements following dietary review by a nutritionist. Clinicians should be cognizant of VKD in patients on blenderized tube feeds which may not meet the adequate intake (AI) goals. In patients who are not receiving nutritionally complete formulas or receiving inadequate volumes, it is important to monitor macro and micronutrients.
|
33 |
Vitamin D and K status and bone health in pediatric cystic fibrosis patientsDrury, Donna. January 2006 (has links)
No description available.
|
34 |
Naphthoquinone StudiesPadgett, William A. 08 1900 (has links)
This thesis describes a series of naphthoquinone reactions employing pyridine carboxylic acid derivatives (nicotinic acid derivatives). The products of these reactions will be tested by Parke, Davis and Company for their activity against the tubercle bacillus and other pathogenic microorganisms.
|
35 |
Combination of vitamins K₂ & D₃ supplementation enhances bone anabolism in type 2 diabetes-associated osteoporosis / CUHK electronic theses & dissertations collectionJanuary 2014 (has links)
Despite numerous studies have demonstrated an association of type 2 diabetes mellitus (T2DM) and osteoporosis, the underlying mechanism connecting these two conditions remains elusive. Clinically, combined calcium and vitamin D supplement is the commonest osteoporosis therapy; however, recent studies have suggested an increase in cardiovascular risks associated with calcium plus vitamin D supplementation. Therefore, an alternative strategy in treating osteoporosis patients with T2DM is urgently needed. In this study, we hypothesized that combined administration of menaquinone-4 (vitamin K₂, biologically active form of vitamin K) and 1α,25-dihydroxyvitamin D₃ (vitamin D₃, biologically active form of vitamin D) as a novel therapy in treating osteoporosis of T2DM patients. Anabolic effect of vitamin K₂ and vitamin D₃, alone or in combination, was assessed on primary osteoblasts harvested from the iliac crests of C57BL/KsJ lean (db⁺/m⁺) and obese/diabetic (db⁺/db⁺, leptin receptor-deficient) mice. Furthermore, the underlying cellular mechanism was also investigated. Serum undercarboxylated osteocalcin (an indication of vitamin K₂ level) level was higher whereas vitamin D₃ level was lower in db⁺/db⁺ mice, and sections of the iliac crests of db⁺/db⁺ mice illustrated extensive porous structures filled with enlarged adipocytes compared with db⁺/m⁺ mice. Lower levels of bone anabolic markers and bone formation transcription factors (osteocalcin, Runx2, Dlx5, ATF4, type I collagen, OSX, alkaline phosphatase (ALP) activity, p-Smad1/5/8 and p-ERK1/2) were observed in the osteoblasts of db⁺/db⁺ mice. Acute vitamin D₃ (10 nM) application elicited a more sustained and greater magnitude of increase of [Ca²⁺]ᵢ in osteoblasts of db⁺/m⁺ mice when compared with db⁺/db⁺ mice. A significantly higher level of calcium deposits in osteoblasts was observed in db⁺/m⁺ mice when compared to db⁺/db⁺ mice. Co-administration of vitamin K₂ (10 nM) and vitamin D₃ (10 nM) caused an enhancement of calcium deposits in osteoblasts in both strains of mice. Vitamins K₂ and D₃ co-administration time-dependently (7, 14 and 21 days) increased the levels of bone anabolic markers and transcription factors for bone formation, with a greater magnitude of increase observed in osteoblasts of db⁺/db⁺ mice. Suppressed expression of calcium-sensing receptor (CaSR), F-actin, V-ATPase, vitamin D receptor (VDR) and pregnane X receptor (PXR) observed in osteoblasts of db⁺/db⁺ mice were partially reversed by combined vitamins treatment. Moreover, combined vitamins K₂ plus D₃ treatment significantly enhanced migration and the appearance of surface microvilli and ruffles of osteoblasts of db⁺/db⁺ mice. Effects of combined vitamins K₂ plus D₃ treatment observed in osteoblasts of db⁺/db⁺ and db⁺/m⁺ mice were eradicated by warfarin (20 µM, a vitamin K epoxide reductase inhibitor). Thus, our results illustrate that vitamins K₂ plus D₃ supplementation is a novel therapeutic strategy in treating osteoporosis of T2DM patients. / 儘管大量研究已證明第二類型糖尿病和骨質疏鬆症的關聯,連接這兩個病症的基本機制仍然是難以捉摸的。在臨床上,鈣和維生素D的綜合補充劑是最常見的骨質疏鬆症治療,然而最近的研究卻表明服用鈣和維生素D的綜合補充劑會增加患者的心血管風險,因此急切需要尋找可以給予同時患有骨質疏鬆症和第二類型糖尿病患者的替代治療。在本研究中,我們假設甲萘醌-4(維生素K₂,維生素K生物活性形式)和1α,25 - 二羥基維生素D₃(維生素D₃,維生素D的生物活性形式)可以嘗試在同時患有骨質疏鬆症和第二類型糖尿病患者身上作為一種革新的療法。本研究從C57BL/KsJ瘦削/非糖尿病 (db⁺/m⁺) 的小鼠和肥胖/帶有第二類型糖尿病基因 (db⁺/db⁺) 兼有瘦素受體缺陷的小鼠的髂嵴原始成骨細胞上對維生素K₂和維生素D₃單獨或組合使用的合成代謝作用進行了評估。此外,我們也對該成骨細胞的底層機制進行了一系列的研究。 / 在肥胖/帶有第二類型糖尿病基因的小鼠血清內低羧骨鈣素水平(維生素K₂水平的指標)較高而維生素D水平較低,另外,它們的髂嵴的部分與瘦削/非糖尿病的小鼠相比,呈現出比較廣泛的多孔結構並填滿了擴大的脂肪細胞。從肥胖/帶有第二類型糖尿病基因的小鼠的成骨細胞中,可以觀察到它們的骨合成代謝的標誌物和骨骼形成的轉錄因子 (骨鈣蛋白,Runx2,Dlx5,ATF4,第一類型骨膠原,OSX,鹼性磷酸酶 (ALP) 活性,p-Smad1/5/8和p-ERK1/2) 的水平比較低。急性維生素D₃ (10 nM) 的應用在瘦削/非糖尿病小鼠的成骨細胞比起在肥胖/帶有第二類型糖尿病基因的小鼠的成骨細胞引起更持續和更大幅度的細胞內鈣變化增加。在瘦削/非糖尿病小鼠的成骨細胞中比起在肥胖/帶有第二類型糖尿病基因的小鼠的成骨細胞有顯著較高的鈣沉積形成。維生素K₂ (10 nM) 和維生素D₃ (10 nM) 的綜合藥在兩種小鼠的成骨細胞中可以有效地增強鈣沉積的形成。維生素K₂和維生素D₃的綜合藥對增加骨合成代謝的標誌物和骨形成轉錄因子的水平有時間依賴性 (7,14和21日),療程越長至21日,在肥胖/帶有第二類型糖尿病基因小鼠的成骨細胞中有更大的幅度的增加。合併維生素治療能部分有效地逆轉在肥胖/帶有第二類型糖尿病基因小鼠的成骨細胞中被抑制表達的鈣敏感受體 (CASR),F-肌動蛋白,V-ATP酶,維生素D受體 (VDR) 和孕烷X受體 (PXR)。此外,結合維生素K₂加維生素D₃治療顯著增強了肥胖/帶有第二類型糖尿病基因小鼠的成骨細胞的細胞遷移和增加了成骨細胞表面外觀的微絨毛和褶皺。在瘦削/非糖尿病小鼠的成骨細胞及肥胖/帶有第二類型糖尿病基因的小鼠的成骨細胞上結合維生素K₂加維生素D₃的治療效果被華法林 (20 μM,維生素K環氧化物還原酶抑製劑) 根除。因此,我們的結果証明了維生素K₂加維生素D₃補充劑的結合使用可有效地作為治療第二類型糖尿病患者並患有骨質疏鬆症的一種新的治療策略。 / Poon, Chui Wa Christina. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2014.n5203 / Includes bibliographical references (leaves 135-151). / Abstracts also in Chinese. / Title from PDF title page (viewed on 26, October, 2016). / Detailed summary in vernacular field only. / Detailed summary in vernacular field only.
|
36 |
Vitamin E : elucidation of the mechanism of side chain degradation and gene regulatory functions / Vitamin E : elucidation of the mechanism of side chain degradation and gene regulatory functionsLandes, Nico January 2005 (has links)
For more than 80 years vitamin E has been in the focus of scientific research. Most of the progress concerning non-antioxidant functions, nevertheless, has only arisen from publications during the last decade.<br>
Most recently, the metabolic pathway of vitamin E has been almost completely elucidated. Vitamin E is metabolized by truncation of its side chain. The initial step of an omega-hydroxylation is carried out by cytochromes P450 (CYPs). This was evidenced by the inhibition of the metabolism of alpha-tocopherol by ketoconozole, an inhibitor of CYP3A expression, whereas rifampicin, an inducer of CYP3A expression increased the metabolism of alpha-tocopherol. Although the degradation pathway is identical for all tocopherols and tocotrienols, there is a marked difference in the amount of the release of metabolites from the individual vitamin E forms in cell culture as well as in experimental animals and in humans. Recent findings not only proposed an CYP3A4-mediated degradation of vitamin E but also suggested an induction of the metabolizing enzymes by vitamin E itself.<br>
In order to investigate how vitamin E is able to influence the expression of metabolizing enzymes like CYP3A4, a pregnane X receptor (PXR)-based reporter gene assay was chosen. PXR is a nuclear receptor which regulates the transcription of genes, e.g., CYP3A4, by binding to specific DNA response elements. And indeed, as shown here, vitamin E is able to influence the expression of CYP3A via PXR in an in vitro reporter gene assay. Tocotrienols showed the highest activity followed by delta- and alpha-tocopherol. An up-regulation of Cyp3a11 mRNA, the murine homolog of the human CYP3A4, could also be confirmed in an animal experiment. The PXR-mediated change in gene expression displayed the first evidence of a direct transcriptional activity of vitamin E. PXR regulates the expression of genes involved in xenobiotic detoxification, including oxidation, conjugation, and transport. CYP3A, e.g., is involved in the oxidative metabolism of numerous currently used drugs. This opens a discussion of possible side effects of vitamin E, but the extent to which supranutritional doses of vitamin E modulate these pathways in humans has yet to be determined.
<br><br>
Additionally, as there is arising evidence that vitamin E's essentiality is more likely to be based on gene regulation than on antioxidant functions, it appeared necessary to further investigate the ability of vitamin E to influence gene expression. Mice were divided in three groups with diets (i) deficient in alpha-tocopherol, (ii) adequate in alpha-tocopherol supply and (iii) with a supranutritional dosage of alpha-tocopherol. After three months, half of each group was supplemented via a gastric tube with a supranutritional dosage of gamma-tocotrienol per day for 7 days. Livers were analyzed for vitamin E content and liver RNA was prepared for hybridization using cDNA array and oligonucleotide array technology. A significant change in gene expression was observed by alpha-tocopherol but not by gamma-tocotrienol and only using the oligonucleotide array but not using the cDNA array. The latter effect is most probably due to the limited number of genes represented on a cDNA array, the lacking gamma-tocotrienol effect is obviously caused by a rapid degradation, which might prevent bioefficacy of gamma-tocotrienol.<br>
Alpha-tocopherol changed the expression of various genes. The most striking observation was an up-regulation of genes, which code for proteins involved in synaptic transmitter release and calcium signal transduction. Synapsin, synaptotagmin, synaptophysin, synaptobrevin, RAB3A, complexin 1, Snap25, ionotropic glutamate receptors (alpha 2 and zeta 1) were shown to be up-regulated in the supranutritional group compared to the deficient group. The up-regulation of synaptic genes shown in this work are not only supported by the strong concentration of genes which all are involved in the process of vesicular transport of neurotransmitters, but were also confirmed by a recent publication. However, a confirmation by real time PCR in neuronal tissue like brain is now required to explain the effect of vitamin E on neurological functionality. The change in expression of genes coding for synaptic proteins by vitamin E is of principal interest thus far, since the only human disease directly originating from an inadequate vitamin E status is ataxia with isolated vitamin E deficiency. Therefore, with the results of this work, an explanation for the observed neurological symptoms associated with vitamin E deficiency can be presented for the first time. / Chemisch handelt es sich bei Vitamin E um acht lipophile Derivate des 6 Chromanols mit einer Seitenkette. Nach dem Sättigungsgrad der Seitenkette lassen sich die Derivate in die Tocopherole (gesättigte Seitenkette) und die Tocotrienole (ungesättigte Seitenkette mit drei Doppelbindungen) einteilen. Entsprechend der Methylierung des Chromanrings lassen sie sich in alpha-, beta-, gamma- und delta-Tocopherol, bzw. Tocotrienol unterscheiden. Davon besitzt alpha-Tocopherol, das gleichzeitig die im Plasma dominierende Form darstellt, die höchste biologische Aktivität. Aufnahme wie auch der Transport von Vitamin E im Körper sind vergleichsweise gut erforscht. Die Kenntnisse zu Metabolismus und Elimination waren jedoch bis vor kurzem sehr lückenhaft. Lange Zeit waren nur Vitamin E-Metabolite mit geöffnetem Chromanring, die sogenannten Simon-Metabolite Tocopheronsäure und Tocopheronolacton bekannt. Diese Metabolite können nur aus oxidativ gespaltenem Vitamin E entstehen und galten daher auch als Beweis für die antioxidative Wirkung von Vitamin E. Mit verbesserter Analytik wurde vor einigen Jahren gezeigt, dass die Simon-Metabolite größtenteils Isolierungsartefakte sind. Stattdessen wurden Metabolite mit intaktem Chromanring identifiziert. Tocopherole wie auch Tocotrienole werden im Körper durch eine Verkürzung der Seitenkette abgebaut. Die Endprodukte sind in jedem Fall CEHCs (Carboxyethyl Hydroxychromane). Die Seitenkettenverkürzung startet mit einer omega-Hydroxylierung gefolgt von 5 Schritten beta-Oxidation. Die omega Hydroxylierung der Seitenkette durch Cytochrom P450 (CYP) Enzyme wurde indirekt bestätigt. CYP3A4 gilt dabei als eines der wahrscheinlichsten Enzyme im Abbau von Vitamin E, die Beteiligung weiterer CYPs wird jedoch gleichfalls angenommen. Auffällig ist, dass nicht alle Vitamin E-Formen in gleichem Ausmaß abgebaut werden. Die Ausscheidung von CEHCs aus alpha-Tocopherol ist, verglichen zu andern Vitamin E-Formen, in kultivierten Zellen wie auch in vivo sehr gering. Die Art der Seitenkettenverkürzung von Vitamin E spricht für einen Abbau über das Fremdstoff-metabolisierende System, welches auch eine Vielzahl von Medikamenten verstoffwechselt.<br>
Im ersten Teil der vorliegenden Arbeit konnte mittels Reportergenassay in HepG2 Zellen gezeigt werden, dass Vitamin E einen nukleären Rezeptor, den Pregnan X Rezeptor (PXR), zu aktivieren und die Expression von PXR-regulierten Genen zu beeinflussen vermag. PXR reguliert eine Reihe von Genen für Fremdstoff-metabolisierende Enzyme wie z.B. Cytochrom P450 3A4 durch Bindung an sein responsives Element im Promotor der Zielgene. Die untersuchten Vitamin E-Formen unterschieden sich deutlich hinsichtlich ihrer PXR-Aktivierung. Die Tocotrienole zeigten die höchste PXR-Aktivierung - vergleichbar mit Rifampicin, einem bekannt guten PXR-Aktivator - gefolgt von delta / alpha- und gamma-Tocopherol. Im Tierversuch an Mäusen konnte die erhöhte Expression von Cyp3a11, dem Homolog des humanen CYP3A4 in Abhängigkeit von der alpha-Tocopherol-Zufuhr bestätigt werden. Somit konnte erstmals gezeigt werden, dass Vitamin E die Expression von Genen direkt beeinflussen kann. Darüber hinaus unterstreicht diese Beobachtung die Möglichkeit einer Wechselwirkung von pharmakologischen Dosen Vitamin E mit dem Abbau von Medikamenten.
Eine genregulatorische Funktion von Vitamin E ist auf den ersten Blick überraschend. Denn wenngleich Vitamin E vor über 80 Jahren als Fertilitätsfaktor bei Ratten entdeckt wurde, steht die erst später beschriebene antioxidative Eigenschaft von Vitamin E bis heute im Fokus der meisten Publikationen. Die molekularen Mechanismen der Essentialität von Vitamin E wurden dagegen wenig untersucht. Erst in den letzten Jahren finden Funktionen von Vitamin E Interesse, die über seine antioxidative Wirkung hinausgehen. Dabei konnte gezeigt werden, dass Vitamin E in vitro die Expression von Genen wie dem Scavenger Rezeptor CD36, dem Connective Tissue Growth Factor oder dem Peroxisomen-Proliferator aktivierten Rezeptor gamma beeinflussen kann.<br>
Um weitere Zielgene von Vitamin E in vivo identifizieren zu können, wurden im zweiten Teil der vorliegenden Arbeit Mäuse in drei Fütterungsgruppen mit einer a) defizientem b) adäquatem sowie c) mit einer supranutritiven alpha Tocopherol-Versorgung über 3 Monate gefüttert. Zusätzlich erhielt die Hälfte der Tiere aus jeder Gruppe während der letzten Lebenswoche eine supranutritive Dosis gamma-Tocotrienol pro Tag. Aus den Lebern der Tiere wurde die RNA präpariert und die differentielle Genexpression mittels a) cDNA und b) Oligonukleotide enthaltenden GenChips analysiert.<br>
Eine signifikante Änderung in der Genexpression zwischen den verschiedenen Fütterungsgruppen fand sich jedoch nur in den Analysen der Oligonukleotid GenChips. Dies kann auf die begrenzte Anzahl von Genen zurückzuführen sein, die auf den cDNA GenChips repräsentiert waren. Auch ein signifikanter Effekt von gamma-Tocotrienol auf die Genexpression konnte nicht beobachtet werden. Wahrscheinlich ist die hohe Ausscheidung von gamma-CEHC, dem Abbauprodukt von gamma-Tocotrienol, die im Urin der Tiere gemessen wurde und die damit womöglich verringerte Bioverfügbarkeit von gamma-Tocotrienol dafür verantwortlich.<br>
Mit Hilfe der Oligonukleotid GenChips konnte jedoch ein signifikanter
Effekt von alpha-Tocopherol auf die Expression einer Vielzahl von Genen beobachtet werden. Herausstechend war dabei die erhöhte Expression von für den vesikulären Transport essentiellen Genen, die für den synaptischen Signaltransfer benötigt werden. So wurden z.B. Synapsin, Synaptotagmin, Synaptophysin, Synaptobrevin, RAB3A, Complexin 1, Snap25, die ionotrophen Glutamat Rezeptoren alpha 2 und zeta 1 in Abhängigkeit von der alpha Tocopherol-Versorgung über die Diät erhöht exprimiert. Die Beobachtung, dass Vitamin E bei neurologischen Prozessen eine Rolle zu spielen scheint ist jedoch nicht neu. Bei Patienten mit einem Mangel an funktionellem alpha-Tocopherol-Transfer-Protein (alpha-TTP) kann es zu stark verringerten Plasmakonzentrationen an Vitamin E kommen, da alpha-TTP eine zentrale Rolle in der Aufnahme und Verteilung von Vitamin E im Körper einnimmt. An diesen Patienten können charakteristische Vitamin E-Mangelzustände beobachtet, die durch eine Reihe von neurologischen Störungen wie Ataxien, Hyporeflexie sowie eine verringerte propriozeptive und vibratorische Sensitivität gekennzeichnet sind. Mit den vorliegenden Ergebnissen kann nun erstmals eine mechanistische Erklärung für diese Symptome diskutiert werden. Eine Bestätigung der vorliegenden Ergebnisse via RT-PCR und Western Blot, z.B. in neuronalem Gewebe wie dem Gehirn, sowie anschließende funktionellen Untersuchungen ist daher dringend geboten.
|
37 |
Vitamine K et fonctions cognitives chez la personne âgée en santé : une approche épidémiologique nutritionnellePresse, Nancy 07 1900 (has links)
La vitamine K fait l’objet d’un intérêt croissant en regard du rôle qu’elle peut jouer dans la santé humaine hormis celui bien établi dans la coagulation sanguine. De plus en plus d’études expérimentales lui confèrent des fonctions dans le système nerveux central, particulièrement dans la synthèse des sphingolipides, l’activation de la protéine vitamine K-dépendante Gas6 et la protection contre les dommages oxydatifs. Toutefois, il demeure beaucoup moins bien établi si la perturbation de ces fonctions peut conduire à des déficits cognitifs. L’objectif principal de cette thèse est de vérifier l’hypothèse selon laquelle le statut vitaminique K des personnes âgées en santé est un déterminant de la performance cognitive. En vue de la réalisation de cet objectif, une meilleure compréhension des indicateurs du statut vitaminique K s’avérait nécessaire. Chacune des études présentées vise donc un objectif spécifique : 1) évaluer le nombre de rappels alimentaires de 24 heures non consécutifs nécessaire pour mesurer l’apport habituel de vitamine K des personnes âgées; 2) évaluer la valeur d’une seule mesure de la concentration sérique de vitamine K comme marqueur de l’exposition à long terme; et 3) examiner l’association entre le statut vitaminique K et la performance cognitive des personnes âgées en santé de la cohorte québécoise NuAge. Trois dimensions cognitives ont été évaluées soient la mémoire épisodique verbale et non-verbale, les fonctions exécutives et la vitesse de traitement de l’information.
Cette thèse présente la première étude appuyant l’hypothèse d’un rôle de la vitamine K dans la cognition chez les personnes âgées. Spécifiquement, la concentration sérique de vitamine K a été associée positivement à la performance en mémoire épisodique verbale, et plus particulièrement au processus de consolidation de la trace mnésique. En accord avec les travaux chez l’animal et l’action de la protéine Gas6 dans l’hippocampe, un rôle spécifique de la vitamine K à l’étape de consolidation est biologiquement plausible. Aucune association significative n’a été observée avec les fonctions exécutives et la vitesse de traitement de l’information. Parallèlement, il a été démontré qu’une mesure unique de la concentration sérique de vitamine K constitue une mesure adéquate de l’exposition à long terme à la vitamine K. De même, il a été établi que six à 13 rappels alimentaires de 24 heures sont nécessaires pour estimer précisément l’apport de vitamine K des personnes âgées en santé. Collectivement, les résultats de ces deux études fournissent des informations précieuses aux chercheurs permettant une meilleure interprétation des études existantes et une meilleure planification des études futures. Les résultats de cette thèse constituent une avancée importante dans la compréhension du rôle potentiel de la vitamine K dans le système nerveux central et renforce la nécessité qu’elle soit considérée en tant que facteur nutritionnel du vieillissement cognitif, en particulier chez les personnes traitées par un antagoniste de la vitamine K. / There is an increasing interest in the potential roles of vitamin K in human health aside from the one well established in blood clotting. Notably, a growing number of experimental studies show that vitamin K has biological functions in the central nervous system, particularly in the synthesis of sphingolipids, the activation of the vitamin K-dependent protein Gas6, and the prevention of oxidative damage. However, it remains uncertain whether the disruption of these functions can lead to cognitive deficits. The main objective of this thesis is to test the hypothesis that vitamin K status is a determinant of cognitive performance in healthy older adults. In order to achieve this goal, a better understanding of vitamin K status indicators was needed. Accordingly, three studies are presented each aiming at a specific objective: 1) estimate the number of non-consecutive 24-hour dietary recalls needed to assess usual vitamin K intake; 2) determine whether a single measurement of serum vitamin K concentration is an adequate indicator of long-term vitamin K exposure; and 3) examine the association between vitamin K status and cognitive performance in healthy older adults from the Québec NuAge Study. Three cognitive domains were assessed namely verbal and non-verbal episodic memory, executive functions, and speed of processing.
This thesis presents the first study providing support for a role of vitamin K in cognition in older adults. Specifically, serum vitamin K concentration was positively associated with performance in verbal episodic memory, particularly in the consolidation process of the memory trace. Consistent with rodent studies and the action of the protein Gas6 in the hippocampus, a specific role of vitamin K in memory consolidation is biologically plausible. No significant association was observed with executive functions and speed of processing. Additionally, it was established that a single measurement of serum vitamin K concentration is adequate for assessing long-term vitamin K exposure in healthy older adults. Similarly, it was determined that six to 13 24-hour dietary recalls are needed to accurately assess usual vitamin K intake. Collectively, both studies provide valuable information to researchers for better interpretation of existing studies and planning future ones. Results from this thesis constitute an important step in the understanding of the potential role of vitamin K in the central nervous system, emphasizing the need to consider this micronutrient as a nutritional factor of cognitive aging, especially among those treated with vitamin K antagonists.
|
38 |
Investigação bioquímica da ocorrência da biossíntese de vitamina K e retinóides no ciclo intraeritrocitário do Plasmodium falciparum. / Biochemical investigation of occurence of retinoids and vitamin K biosynthesis in intraerythrocytic stages of Plasmodium falciparum.Matsumura, Miriam Yukiko 14 November 2008 (has links)
A malária é uma das principais doenças parasitárias no mundo, e o aumento da resistência aos antimaláricos atualmente utilizados dificulta o controle dessa parasitose. Assim, é de interesse a descoberta de novas vias metabólicas que sirvam de alvos para o desenvolvimento de drogas para combater essa doença. Nosso laboratório, nos últimos anos, tem investido na caracterização de intermediários e produtos finais da via de isoprenóides. Baseando-se na presença das vias 2-C-metil-D-eritritol 4-fosfato e do chiquimato, decidimos verificar se ocorriam as biossínteses de retinóides e vitamina K no ciclo intraeritrocitário do P. falciparum, através da análise de produtos metabolicamente marcados com [1(n)-3H]-pirofosfato de geranilgranila por análises cromatográficas (HPLC e TLC), além da espectrometria de massas. Não identificamos a presença de retinal, retinol e ácido retinóico no ciclo intraeritrocitário do P. falciparum. Já a biossíntese de vitamina K precisa ser estudada com mais profundidade, pois há indícios de biossíntese, em especial da menaquinona-4. / Malaria is one of the most important parasitic diseases in the world. The spread of resistance to the antimalarials impairs the parasite\'s control. Therefore, is necessary the discovery of new metabolic routes to allow new antimalarials development. Our group has been studying the isoprenoid pathway, characterizing the intermediate and secondary products of this pathway. Based on the presence of 2-C-methyl-D-erythritol 4-phosphate and shikimate pathways, we decided to investigate the occurrence of retinoids and vitamin K biosynthesis in P. falciparum, through the chromatography of [1(n)-3H]Geranylgeranylpyrophosphate labeled products of intraerythrocytic stages of P. falciparum, and mass espectometry analysis. The retinal, retinol and retinoic acid were not identified in P. falciparum. The results indicate the menaquinone-4 biosynthesis, although deeper investigation is necessary.
|
39 |
Ingestão de vitamina K por indivíduos de diferentes faixas etárias / Vitamin K intake by individuals of different age groupsSouza, Wysllenny Nascimento de 24 November 2011 (has links)
A vitamina K é um co-fator importante no processo de coagulação sanguínea e recentemente estudos têm demonstrado os benefícios de sua ingestão sobre o metabolismo ósseo. Dessa forma, a atual recomendação de ingestão dietética para esta vitamina vem sendo questionada, pois se acredita que o requerimento da mesma para a função óssea é muito mais alto do que os necessários para manter a homeostase sanguínea. No Brasil, poucos estudos avaliaram a ingestão de vitamina K em populações saudáveis. Assim, o principal objetivo deste trabalho é avaliar a ingestão de vitamina K em adultos e idosos saudáveis. Foi realizado um estudo transversal com a participação de 173 indivíduos de ambos os sexos. A ingestão dietética de cada participante foi avaliada através da aplicação de três recordatórios 24h não consecutivos. As variabilidades intra e interpessoal foram avaliadas utilizando o software PC-SIDE. Para verificar qual grupo de alimentos que mais contribuiu para ingestão de vitamina K foi feita uma análise dos componentes principais. Os adultos representaram 49,7% da amostra e 65, 3% da população eram do gênero feminino. A média de ingestão de vitamina K na amostra foi de 110,7 µg/dia, com uma mediana de 99 µg/dia, os idosos foram os que apresentaram maiores valores de ingestão com uma mediana de 104 µg/ dia. A ingestão de vitamina K através do consumo de gorduras foi estatisticamente diferente entre as faixas etárias, sendo esta diferença mais acentuada entre adultos jovens e idosos (p=0, 006). O consumo de vitamina K entre adultos e idosos apresentou diferença estatística (p=0,00) e o consumo de hortaliças apresentou forte correlação com o consumo de vitamina K total. Logo, conclui-se que independentemente da faixa etária e do sexo, a ingestão de vitamina K foi insuficiente em quase metade da amostra, o que pode ocasionar um maior risco de inadequação dietética. Isso é preocupante, pois pode acarretar problemas ósseos no futuro e/ou agravar os já presentes quando se trata da população idosa. / Vitamin K is an important cofactor in the blood coagulation process and recent researches have demonstrated benefits of vitamin K intake on bone metabolism. Thus, a current dietary recommendation for this vitamin has been questioned; it is believed that the requirement of this vitamin for this bone function is much higher than that necessary to maintain blood homeostasis. In Brazil, few studies evaluated the intake of vitamin K in healthy populations. Therefore, the aim of this study is to evaluate the intake of vitamin K in healthy adults and the elderly. A cross-sectional study involving 173 subjects of both sexes was conducted. The dietary intake of each participant was evaluated by applying three non-consecutive 24h recalls. The within- to between-person variability was evaluated using the PC-SIDE software. To determine which food group most contributed to the intake of vitamin K, an analysis of the major components was performed. Adults represented 49.7% of the subjects and 65.3% of the populations were female. The mean intake of vitamin K in the sample was 110.7 mg/day and median of 99 mg/day; the elderly presented the highest values with median intake of 104 mg/day. Vitamin K intake by consuming fats differ statistically between age groups; this difference was more pronounced among young adults and the elderly (p=0.006). The intake of vitamin K among adults and the elderly showed a statistical difference (p=0.00) and vegetable intake showed a strong correlation with the total intake of vitamin K. It can thus be concluded that independently of age and gender, the intake of vitamin K was insufficient in nearly half of the subjects, which can cause an increased risk of dietary inadequacy. This is worrying because it could cause bone disorders in the future and/or exacerbate those already present when it comes to the elderly population.
|
40 |
Caracterização da função biológica da vitamina K biossintetizada pelas formas intraeritrocitárias de Plasmodium falciparum. / Analysis of the biological function of the vitamin K biosynthesized by intraerytrocytic forms of Plasmodium falciparum.Gabriel, Heloisa Berti 11 February 2011 (has links)
A falta de uma vacina eficaz e o problema da resistência aos fármacos têm dificultado o controle da malária. A busca de novos alvos biológicos para o desenvolvimento de antimaláricos eficazes tem se concentrado, em parte, na pesquisa e compreensão de vias metabólicas exclusivas do parasita. Nosso grupo vem investigando e caracterizando produtos da biossíntese de isoprenóides em P. falciparum. Resultados preliminares identificaram a biossíntese das duas formas da vitamina K: filoquinona (PhQ) e menaquinona (MQ), ambas provenientes das vias do chiquimato e da via 2-C-metil-D-eritritol-4-fosfato (MEP). Salienta-se, ainda, que as vias do chiquimato e MEP são exclusivas do parasita, portanto alvos interessantes para o estudo e desenvolvimento de drogas alternativas contra a malária. Ensaios enzimáticos demonstraram a participação da MQ-4 na cadeia respiratória como transportadora de elétrons. Resultados indicaram que o parasita controla a concentração de ubiquinona e menaquinona (UQ/MQ) de acordo com as condições de aeração a qual é submetido, assim como descrito em E. coli e Ascaris suum. A biossíntese de MQ em P. falciparum é bloqueada pelo composto Ro 48-8071, inibidor da enzima 1,4-dihidroxi-2-naftoato preniltransferase da via de biossíntese de MQ. Em relação a PhQ, dados preliminares mostram uma provável participação na proteção antioxidante no ciclo intraeritrocítico de P. falciparum. Finalmente, por meio de ensaios de Real Time-PCR, investigou-se o padrão de transcrição de prováveis genes que supostamente codificariam algumas enzimas da via de biossíntese de MQ, PhQ, e UQ (esse último previamente caracterizado). Os resultados demonstraram que não há alterações na transcrição desses genes prováveis nos parasitas mantidos em diferentes condições de pressão de O2. / The lack of an effective vaccine and the problem of drug resistance haves hampered the control of malaria. The search for new biological targets for the development of effective antimalarials in part has focused on research and understanding of metabolic pathways unique to the parasite. Our group has investigated and characterized the products of the isoprenoids biosynthesis in P. falciparum. Preliminary results have identified the biosynthesis of two forms of vitamin K: phylloquinone (PhQ) and menaquinone (MQ), both derived from the Shikimate pathway and 2-C-methyl-D-erythritol-4-phosphate pathway (MEP). The shikimate and MEP pathways are unique to the parasite therefore are interesting targets for study and development of alternative drugs against the malaria. The enzimatic assay showed the participation of MQ-4 in the respiratory chain as electron carrier. Results indicated that the parasite controls the concentration of ubiquinone and menaquinone (UQ / MQ) according to the aeration conditions which is submitted, as described in E. coli and Ascaris suum. The MQ biosynthesis in P. falciparum is blocked by the compound Ro 48-8071, an inhibitor of the enzyme 1,4-dihydroxy-2-naftoato prenyltransferase. Also was described in the parasite, the biosynthesis of another form of vitamin K (PhQ) , and preliminary results showed probably participation of PhQ in the antioxidant protection in the cycle of P. falciparum. Finally, by the Real Time-PCR, we investigated the pattern of transcription of putative genes some enzymes of MQ, PhQ and UQ biosynthesis (the last was previously characterized). The results showed no changes in the transcription profile in the parasites kept in different conditions of O2 pressure.
|
Page generated in 0.0665 seconds